MetLife Announces Second Quarter 2012 Results
August 01, 2012
– Operating Earnings of $1.4 Billion, or $1.33 Per Share, up 18% from
2Q 2011 – – Net Income of $2.3 Billion, or $2.12 Per Share, Including
Derivative Gains Due to Lower Interest Rates & Impact of MetLife’s
Credit Spreads – – Book Value Excluding Accumulated Other Comprehensive Income Grows
12% Over 2Q 2011 to $48.60 Per Share – NEW YORK--(BUSINESS WIRE)--
MetLife, Inc. (NYSE: MET) today reported second quarter 2012 net income
of $2.3 billion, or $2.12 per share, and operating earnings1
of $1.4 billion, or $1.33 per share.
“MetLife continued to perform well in the second quarter particularly
given the current environment,” said Steven A. Kandarian, chairman,
president and chief executive officer of MetLife, Inc. “Our story is
clear – consistent execution on the fundamentals of the business. Our
underwriting discipline is paying off, our investment income and core
spreads are healthy, and we’re successfully managing through the
low-interest-rate environment.”
Net income included net derivative gains of $1.4 billion, after tax,
largely due to decreases in interest rates and the impact of MetLife’s
credit spreads during the quarter. As part of its broader
asset-liability management strategy, MetLife uses derivatives to hedge
certain risks, such as movements in interest rates and foreign
currencies. This hedging activity often generates derivative gains or
losses and creates fluctuations in net income because the risk being
hedged may not have the same GAAP accounting treatment. Also, derivative
gains or losses related to MetLife’s credit spreads do not have an
economic impact on the company.
|
___________
| 1 Information regarding the non-GAAP financial measures
included in this press release and the reconciliation of the
historical non-GAAP financial measures to GAAP measures is
provided in the Non-GAAP and Other Financial Disclosures
discussion below, as well as in the tables that accompany this
release and/or the Second Quarter 2012 Financial Supplement.
|
SUMMARY -
Second quarter 2012 operating earnings of $1.4 billion, or $1.33 per
share, up 18% over the second quarter of 2011 driven by all three
geographic regions
-
Book value excluding accumulated other comprehensive income of $48.60
per share, up 12% over the second quarter of 2011
-
Net investment income of $5.2 billion, up 4% over the second quarter
of 2011 and reflecting:
-
solid recurring income, which drove strong investment spreads, and
-
variable investment income above the plan range by $79 million, or
$0.07 per share, after tax and the impact of deferred acquisition
costs (“DAC”)
|
|
|
|
|
| |
($ in millions, except per share data)
|
|
|
| For the three months ended June 30, | | | | | | 2012 |
| | 2011 |
| Change | |
Premiums, fees & other revenues
| | | |
$
|
11,602
| |
$
|
11,636
| |
–
| | |
Total operating revenues
| | | |
$
|
16,789
| |
$
|
16,647
| |
1
|
%
| | | | | | | | | | | |
| |
Net income (loss)
| | | |
$
|
2,264
| |
$
|
1,069
| |
–
| | |
Net income (loss) per share
| | | |
$
|
2.12
| |
$
|
1.00
| |
–
| | | | | | | | | | | | |
| |
Operating earnings
| | | |
$
|
1,426
| |
$
|
1,207
| |
18
|
%
| |
Operating earnings per share
| | | |
$
|
1.33
| |
$
|
1.13
| |
18
|
%
| | | | | | | | | | | |
| |
Book value per share
| | | |
$
|
56.83
| |
$
|
46.56
| |
22
|
%
| |
Book value per share, excluding AOCI
|
|
|
|
$
| 48.60 |
|
$
|
43.24
|
| 12 |
%
| | | | | | | | |
|
BUSINESS DISCUSSIONS
All comparisons of second quarter 2012 results in the business
discussions that follow are with the second quarter of 2011, unless
otherwise noted. All comparisons on a constant currency basis are
calculated using the average foreign currency exchange rates for the
current period and are applied to the prior period. Reconciliations of
segment net income to segment operating earnings are provided in the
tables that accompany this release and in the Second Quarter 2012
Financial Supplement, which is available on the Investor Relations
section of www.metlife.com.
THE AMERICAS
Total operating earnings for the Americas increased 11% to $1.1 billion
driven by strong earnings growth in Retail as well as Group, Voluntary &
Worksite Benefits. Premiums, fees & other revenues for the Americas were
down slightly at $8.4 billion, largely due to a decline in pension
closeout sales, which often fluctuate significantly from quarter to
quarter.
Retail
Operating earnings for Retail – which includes U.S. retail life
insurance and annuities – were $380 million, up 14% due to favorable
investment margins, higher fees and lower expenses. Premiums, fees &
other revenues for Retail were $2.4 billion, up 3% as higher annuity
fees were partially offset by lower income annuity and life sales.
Variable annuity sales were $4.6 billion, down 34%.
Group, Voluntary & Worksite Benefits
Operating earnings for Group, Voluntary & Worksite Benefits – which
includes U.S. group life, non-medical health and property & casualty
insurance – were $295 million, up 29% mainly due to favorable claims
experience in the non-medical health business and lower catastrophes in
the property & casualty business. While catastrophes were lower compared
with the record levels in the second quarter of 2011, they were $44
million, or $0.04 per share, after tax, above the company’s quarterly
plan provision for the second quarter of 2012. These higher than
expected catastrophes were partially offset by favorable non-catastrophe
claim development related to prior accident years of $25 million, or
$0.02 per share, after tax, in the second quarter of 2012.
Premiums, fees & other revenues for Group, Voluntary & Worksite Benefits
were $4.5 billion, up 4% due to growth across the businesses, including
favorable sales and persistency in group life as well as higher dental,
disability and property & casualty revenues.
Corporate Benefit Funding
Operating earnings for Corporate Benefit Funding – which includes the
U.S. and U.K. pension closeout businesses, structured settlements and
other benefit funding products – were $318 million, down 2%. Premiums,
fees & other revenues for Corporate Benefit Funding were $645 million,
down 35% due to lower pension closeout sales (which often fluctuate
significantly from quarter to quarter) and a decline in structured
settlement sales.
Latin America
Operating earnings for Latin America were $135 million, up 5% (19% on a
constant currency basis) due to business growth in several countries.
Premiums, fees & other revenues in Latin America increased 1% (13% on a
constant currency basis) to $851 million, largely due to growth in
accident & health insurance in Chile and Argentina as well as higher
immediate annuity sales in Chile. Total sales for the region increased
4%, driven by growth in the accident & health and retirement businesses.
ASIA
Operating earnings for Asia were $275 million, up 61% primarily due to
growth in the business in Japan and strong net investment income. The
prior year period was negatively impacted by the March 2011 tsunami and
earthquake in Japan. Premiums, fees & other revenues in Asia were $2.3
billion, up 6% due to business growth in Japan and Australia as well as
improved persistency in both Japan and Korea. Total sales for the region
grew 13%, driven by higher life sales in Japan, increased accident &
health sales in China and growth in group sales in Australia.
EMEA
Operating earnings for EMEA were $82 million, up 28% (46% on a constant
currency basis) due to business growth in several countries and the
benefit of a one-time item. EMEA premiums, fees & other revenues were
$815 million, down 4%, but up 3% on a constant currency basis. Total
sales for the region increased 13% despite the challenging economic
environment in Europe. Turkey, Russia and the Gulf countries contributed
to the sales growth in the quarter.
INVESTMENTS
Net investment income was $5.2 billion, up 4%. Variable investment
income was above the plan range at $371 million ($242 million, after tax
and DAC) compared with $273 million ($177 million, after tax and DAC) in
the second quarter of 2011.
For the second quarter of 2012, MetLife reported $4 million, after tax,
of investment portfolio net gains compared with investment portfolio net
losses of $34 million, after tax. Derivative net gains were $1.3
billion, after tax and other adjustments, compared with derivative net
gains of $195 million, after tax and other adjustments, in the second
quarter of 2011.
CORPORATE & OTHER
Corporate & Other had an operating loss of $59 million, compared with an
operating loss of $43 million. Higher net investment income in the
second quarter of 2012 was offset by lower earnings from MetLife Bank’s
forward mortgage servicing operations and certain other expenses of $29
million ($0.03 per share), after tax.
Conference Call MetLife will hold its second quarter 2012 earnings conference call and
audio Webcast on Thursday, August 2, 2012, from 8:00 to 9:00 a.m. (ET).
The conference call will be available live via telephone and the
Internet. To listen over the telephone, dial (612) 326-1027. To listen
to the conference call over the Internet, visit www.metlife.com
(through a link on the Investor Relations page). Those who want to
listen to the call on the telephone or via the Internet should dial in
or go to the Web site at least fifteen minutes prior to the call to
register, and/or download and install any necessary audio software.
The conference call will be available for replay via telephone and the
Internet beginning at 10:00 a.m. (ET) on Thursday, August 2, 2012, until
Thursday, August 9, 2012 at 11:59 p.m. (ET). To listen to a replay of
the conference call over the telephone, dial (320) 365-3844. The access
code for the replay is 226302. To access the replay of the conference
call over the Internet, visit the above-mentioned Web site.
About MetLife MetLife, Inc. is a leading global provider of insurance, annuities and
employee benefit programs, serving 90 million customers. Through its
subsidiaries and affiliates, MetLife holds leading market positions in
the United States, Japan, Latin America, Asia, Europe and the Middle
East. For more information, visit www.metlife.com.
Non-GAAP and Other Financial Disclosures
All references in this press release (except in this section) to net
income (loss), net income (loss) per share, operating earnings,
operating earnings per share, book value per share and premiums, fees
and other revenues, should be read as net income (loss) available to
MetLife, Inc.’s common shareholders, net income (loss) available to
MetLife, Inc.’s common shareholders per diluted common share, operating
earnings available to common shareholders, operating earnings available
to common shareholders per diluted common share, book value per common
share and premiums, fees and other revenues (operating), respectively.
Operating earnings is the measure of segment profit or loss that MetLife
uses to evaluate segment performance and allocate resources. Consistent
with accounting principles generally accepted in the United States of
America (“GAAP”) accounting guidance for segment reporting, operating
earnings is MetLife’s measure of segment performance. Operating earnings
is also a measure by which MetLife senior management’s and many other
employees’ performance is evaluated for the purposes of determining
their compensation under applicable compensation plans.
Operating earnings is defined as operating revenues less operating
expenses, both net of income tax. Operating earnings available to common
shareholders is defined as operating earnings less preferred stock
dividends.
Operating revenues and operating expenses exclude results of
discontinued operations and other businesses that have been or will be
sold or exited by MetLife (“Divested businesses”). Operating revenues
also excludes net investment gains (losses) (“NIGL”) and net derivative
gains (losses) (“NDGL”).
The following additional adjustments are made to GAAP revenues, in the
line items indicated, in calculating operating revenues:
-
Universal life and investment-type product policy fees excludes the
amortization of unearned revenue related to NIGL and NDGL and certain
variable annuity guaranteed minimum income benefits (“GMIB”) fees
(“GMIB fees”);
-
Net investment income: (i) includes amounts for scheduled periodic
settlement payments and amortization of premium on derivatives that
are hedges of investments but do not qualify for hedge accounting
treatment, (ii) includes income from discontinued real estate
operations, (iii) excludes post-tax operating earnings adjustments
relating to insurance joint ventures accounted for under the equity
method, (iv) excludes certain amounts related to
contractholder-directed unit-linked investments, and (v) excludes
certain amounts related to securitization entities that are variable
interest entities (“VIEs”) consolidated under GAAP; and
-
Other revenues are adjusted for settlements of foreign currency
earnings hedges.
The following additional adjustments are made to GAAP expenses, in the
line items indicated, in calculating operating expenses:
-
Policyholder benefits and claims and policyholder dividends excludes:
(i) changes in the policyholder dividend obligation related to NIGL
and NDGL, (ii) inflation-indexed benefit adjustments associated with
contracts backed by inflation-indexed investments and amounts
associated with periodic crediting rate adjustments based on the total
return of a contractually referenced pool of assets, (iii) benefits
and hedging costs related to GMIBs (“GMIB costs”), and (iv) market
value adjustments associated with surrenders or terminations of
contracts (“Market value adjustments”);
-
Interest credited to policyholder account balances includes
adjustments for scheduled periodic settlement payments and
amortization of premium on derivatives that are hedges of policyholder
account balances but do not qualify for hedge accounting treatment and
excludes amounts related to net investment income earned on
contractholder-directed unit-linked investments;
-
Amortization of DAC and value of business acquired (“VOBA”) excludes
amounts related to: (i) NIGL and NDGL, (ii) GMIB fees and GMIB costs
and (iii) Market value adjustments;
-
Amortization of negative VOBA excludes amounts related to Market value
adjustments;
-
Interest expense on debt excludes certain amounts related to
securitization entities that are VIEs consolidated under GAAP; and
-
Other expenses excludes costs related to: (i) noncontrolling
interests, (ii) implementation of new insurance regulatory
requirements, and (iii) acquisition and integration costs.
MetLife believes the presentation of operating earnings and operating
earnings available to common shareholders as MetLife measures it for
management purposes enhances the understanding of the company’s
performance by highlighting the results of operations and the underlying
profitability drivers of the business. Operating revenues, operating
expenses, operating earnings, operating earnings available to common
shareholders, operating earnings available to common shareholders per
diluted common share, book value per common share, excluding accumulated
other comprehensive income (“AOCI”) and book value per diluted common
share, excluding AOCI, should not be viewed as substitutes for the
following financial measures calculated in accordance with GAAP: GAAP
revenues, GAAP expenses, GAAP income (loss) from continuing operations,
net of income tax, GAAP net income (loss) available to MetLife, Inc.’s
common shareholders, GAAP net income (loss) available to MetLife, Inc.’s
common shareholders per diluted common share, book value per common
share and book value per diluted common share, respectively.
Reconciliations of these measures to the most directly comparable GAAP
measures are included in the Second Quarter 2012 Financial Supplement
and/or in the tables that accompany this earnings press release.
Statistical sales information for life insurance is calculated by
MetLife using the LIMRA International, Inc. definition of sales for core
direct sales, excluding company sponsored internal exchanges,
corporate-owned life insurance, bank-owned life insurance, and private
placement variable universal life insurance. Individual annuities sales
consists of statutory premiums direct and assumed, excluding company
sponsored internal exchanges.
Forward-Looking Statements
This press release may contain or incorporate by reference information
that includes or is based upon forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of future
events. These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words such as
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe” and other words and terms of similar meaning in connection
with a discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results of
current and anticipated services or products, sales efforts, expenses,
the outcome of contingencies such as legal proceedings, trends in
operations and financial results.
Any or all forward-looking statements may turn out to be wrong. They can
be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Many such factors will be important in determining the
actual future results of MetLife, Inc., its subsidiaries and affiliates.
These statements are based on current expectations and the current
economic environment. They involve a number of risks and uncertainties
that are difficult to predict. These statements are not guarantees of
future performance. Actual results could differ materially from those
expressed or implied in the forward-looking statements. Risks,
uncertainties, and other factors that might cause such differences
include the risks, uncertainties and other factors identified in
MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission
(the “SEC”). These factors include: (1) difficult conditions in the
global capital markets; (2) concerns over U.S. fiscal policy and the
trajectory of the national debt of the U.S., as well as rating agency
downgrades of U.S. Treasury securities; (3) uncertainty about the
effectiveness of governmental and regulatory actions to stabilize the
financial system, the imposition of fees relating thereto, or the
promulgation of additional regulations; (4) increased volatility and
disruption of the capital and credit markets, which may affect our
ability to seek financing or access our credit facilities; (5) impact of
comprehensive financial services regulation reform on us; (6) economic,
political, legal, currency and other risks relating to our international
operations, including with respect to fluctuations of exchange rates;
(7) exposure to financial and capital market risk, including as a result
of the disruption in Europe and possible withdrawal of one or more
countries from the Euro zone; (8) changes in general economic
conditions, including the performance of financial markets and interest
rates, which may affect our ability to raise capital, generate fee
income and market-related revenue and finance statutory reserve
requirements and may require us to pledge collateral or make payments
related to declines in value of specified assets; (9) potential
liquidity and other risks resulting from our participation in a
securities lending program and other transactions; (10) investment
losses and defaults, and changes to investment valuations; (11)
impairments of goodwill and realized losses or market value impairments
to illiquid assets; (12) defaults on our mortgage loans; (13) the
defaults or deteriorating credit of other financial institutions that
could adversely affect us; (14) our ability to address unforeseen
liabilities, asset impairments, or rating actions arising from
acquisitions or dispositions, including our acquisition of American Life
Insurance Company and Delaware American Life Insurance Company
(collectively, “ALICO”) and to successfully integrate and manage the
growth of acquired businesses with minimal disruption; (15) uncertainty
with respect to the outcome of the closing agreement entered into with
the United States Internal Revenue Service in connection with the
acquisition of ALICO; (16) the dilutive impact on our stockholders
resulting from the settlement of common equity units issued in
connection with the acquisition of ALICO or otherwise; (17) MetLife,
Inc.’s primary reliance, as a holding company, on dividends from its
subsidiaries to meet debt payment obligations and the applicable
regulatory restrictions on the ability of the subsidiaries to pay such
dividends; (18) downgrades in our claims paying ability, financial
strength or credit ratings; (19) ineffectiveness of risk management
policies and procedures; (20) availability and effectiveness of
reinsurance or indemnification arrangements, as well as default or
failure of counterparties to perform; (21) discrepancies between actual
claims experience and assumptions used in setting prices for our
products and establishing the liabilities for our obligations for future
policy benefits and claims; (22) catastrophe losses; (23) heightened
competition, including with respect to pricing, entry of new
competitors, consolidation of distributors, the development of new
products by new and existing competitors, distribution of amounts
available under U.S. government programs, and for personnel; (24)
unanticipated changes in industry trends; (25) changes in assumptions
related to investment valuations, deferred policy acquisition costs,
deferred sales inducements, value of business acquired or goodwill; (26)
changes in accounting standards, practices and/or policies; (27)
increased expenses relating to pension and postretirement benefit plans,
as well as health care and other employee benefits; (28) exposure to
losses related to variable annuity guarantee benefits, including from
significant and sustained downturns or extreme volatility in equity
markets, reduced interest rates, unanticipated policyholder behavior,
mortality or longevity, and the adjustment for nonperformance risk; (29)
deterioration in the experience of the “closed block” established in
connection with the reorganization of Metropolitan Life Insurance
Company; (30) adverse results or other consequences from litigation,
arbitration or regulatory investigations; (31) inability to protect our
intellectual property rights or claims of infringement of the
intellectual property rights of others; (32) discrepancies between
actual experience and assumptions used in establishing liabilities
related to other contingencies or obligations; (33) regulatory,
legislative or tax changes relating to our insurance, banking,
international, or other operations that may affect the cost of, or
demand for, our products or services, or increase the cost or
administrative burdens of providing benefits to employees; (34) the
effects of business disruption or economic contraction due to disasters
such as terrorist attacks, cyberattacks, other hostilities, or natural
catastrophes, including any related impact on our disaster recovery
systems, cyber-or other information security systems and management
continuity planning; (35) the effectiveness of our programs and
practices in avoiding giving our associates incentives to take excessive
risks; and (36) other risks and uncertainties described from time to
time in MetLife, Inc.’s filings with the SEC.
MetLife, Inc. does not undertake any obligation to publicly correct or
update any forward-looking statement if MetLife, Inc. later becomes
aware that such statement is not likely to be achieved. Please consult
any further disclosures MetLife, Inc. makes on related subjects in
reports to the SEC.
|
|
|
| |
| |
| |
| | | MetLife, Inc. | | Consolidated Statements of Operating Earnings Available to Common
Shareholders | | (Unaudited) | | | | | | | | | | |
| | | | | | | | | | |
| | | | |
For the Three Months Ended
| |
For the Six Months Ended
| | | | | June 30,
| | June 30,
| | | | |
|
2012
|
| |
|
2011
|
| |
|
2012
|
| |
|
2011
|
| | | | |
(In millions)
| |
(In millions)
| | OPERATING REVENUES | | | | | | | | | | | |
Premiums
| | | |
$
|
9,139
| | |
$
|
9,270
| | |
$
|
18,246
| | |
$
|
17,802
| | |
Universal life and investment-type product policy fees
| | | | |
1,999
| | | |
1,908
| | | |
4,008
| | | |
3,740
| | |
Net investment income
| | | | |
5,187
| | | |
5,011
| | | |
10,272
| | | |
9,794
| | |
Other revenues
| | | |
|
464
|
| |
|
458
|
| |
|
953
|
| |
|
926
|
| |
Total operating revenues
| | | |
|
16,789
|
| |
|
16,647
|
| |
|
33,479
|
| |
|
32,262
|
| | | | | | | | | | |
| | OPERATING EXPENSES | | | | | | | | | | | |
Policyholder benefits and claims and policyholder dividends
| | | | |
9,132
| | | |
9,272
| | | |
18,071
| | | |
17,711
| | |
Interest credited to policyholder account balances
| | | | |
1,525
| | | |
1,508
| | | |
3,064
| | | |
2,987
| | |
Capitalization of DAC
| | | | |
(1,313
|
)
| | |
(1,365
|
)
| | |
(2,675
|
)
| | |
(2,627
|
)
| |
Amortization of DAC and VOBA
| | | | |
1,162
| | | |
1,136
| | | |
2,180
| | | |
2,133
| | |
Amortization of negative VOBA
| | | | |
(164
|
)
| | |
(163
|
)
| | |
(301
|
)
| | |
(326
|
)
| |
Interest expense on debt
| | | | |
299
| | | |
328
| | | |
612
| | | |
651
| | |
Other expenses
| | | |
|
4,113
|
| |
|
4,172
|
| |
|
8,404
|
| |
|
8,062
|
| |
Total operating expenses
| | | |
|
14,754
|
| |
|
14,888
|
| |
|
29,355
|
| |
|
28,591
|
| | | | | | | | | | |
| |
Operating earnings before provision for income tax
| | | | |
2,035
| | | |
1,759
| | | |
4,124
| | | |
3,671
| | |
Provision for income tax expense (benefit)
| | | |
|
578
|
| |
|
521
|
| |
|
1,174
|
| |
|
1,085
|
| |
Operating earnings
| | | | |
1,457
| | | |
1,238
| | | |
2,950
| | | |
2,586
| | |
Preferred stock dividends
| | | |
|
31
|
| |
|
31
|
| |
|
61
|
| |
|
61
|
| | OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | |
$
|
1,426
|
| |
$
|
1,207
|
| |
$
|
2,889
|
| |
$
|
2,525
|
| | | | | | | | | | |
| | | | | | | | | | |
| | Reconciliation to Net Income (Loss) and Financial Statement
Line Item Adjustments from GAAP | | | | | | | | |
Operating earnings
| | | |
$
|
1,457
| | |
$
|
1,238
| | |
$
|
2,950
| | |
$
|
2,586
| | |
Adjustments from operating earnings to income (loss) from continuing
operations:
| | | | | | | | | | | |
Net investment gains (losses)
| | | | |
(64
|
)
| | |
(155
|
)
| | |
(174
|
)
| | |
(254
|
)
| |
Net derivative gains (losses)
| | | | |
2,092
| | | |
352
| | | |
114
| | | |
37
| | |
Premiums
| | | | |
22
| | | |
24
| | | |
44
| | | |
46
| | |
Universal life and investment-type product policy fees
| | | | |
98
| | | |
61
| | | |
167
| | | |
118
| | |
Net investment income
| | | | |
(468
|
)
| | |
83
| | | |
647
| | | |
612
| | |
Other revenues
| | | | |
(71
|
)
| | |
134
| | | |
37
| | | |
232
| | |
Policyholder benefits and claims and policyholder dividends
| | | | |
(131
|
)
| | |
(223
|
)
| | |
(639
|
)
| | |
(393
|
)
| |
Interest credited to policyholder account balances
| | | | |
503
| | | |
66
| | | |
(515
|
)
| | |
(379
|
)
| |
Capitalization of DAC
| | | | |
2
| | | |
2
| | | |
4
| | | |
4
| | |
Amortization of DAC and VOBA
| | | | |
(317
|
)
| | |
(118
|
)
| | |
(13
|
)
| | |
(60
|
)
| |
Amortization of negative VOBA
| | | | |
17
| | | |
20
| | | |
35
| | | |
40
| | |
Interest expense on debt
| | | | |
(43
|
)
| | |
(92
|
)
| | |
(88
|
)
| | |
(184
|
)
| |
Other expenses
| | | | |
(337
|
)
| | |
(403
|
)
| | |
(814
|
)
| | |
(696
|
)
| |
Provision for income tax (expense) benefit
| | | |
|
(460
|
)
| |
|
73
|
| |
|
411
|
| |
|
277
|
| |
Income (loss) from continuing operations, net of income tax
| | | | |
2,300
| | | |
1,062
| | | |
2,166
| | | |
1,986
| | |
Income (loss) from discontinued operations, net of income tax
| | | |
|
3
|
| |
|
31
|
| |
|
17
|
| |
|
(9
|
)
| |
Net income (loss)
| | | | |
2,303
| | | |
1,093
| | | |
2,183
| | | |
1,977
| | |
Less: Net income (loss) attributable to noncontrolling interest
| | | |
|
8
|
| |
|
(7
|
)
| |
|
32
|
| |
|
-
|
| |
Net income (loss) attributable to MetLife, Inc. | | | | |
2,295
| | | |
1,100
| | | |
2,151
| | | |
1,977
| | |
Less: Preferred stock dividends
| | | | |
31
| | | |
31
| | | |
61
| | | |
61
| | |
Less: Preferred stock redemption premium
| | | |
|
-
|
| |
|
-
|
| |
|
-
|
| |
|
146
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
2,264
|
| |
$
|
1,069
|
| |
$
|
2,090
|
| |
$
|
1,770
|
| | | | | | | | | | |
|
|
|
|
| |
| |
| |
| |
|
| |
| |
| |
| | | MetLife, Inc. | | (Unaudited) | | | | | | | | | | | | | | | | | | | |
| | | | |
For the Three Months Ended
| | |
For the Six Months Ended
| | | | | June 30,
| | |
June 30,
| | | | |
2012
| |
2011
| | |
2012
| |
2011
| | | | | | |
Earnings Per Weighted Average Common Shares Diluted
(1)
| |
Earnings Per Weighted Average Common Shares Diluted
| | |
Earnings Per Weighted Average Common Shares Diluted
(1)
| |
Earnings Per Weighted Average Common Shares Diluted
| | | | |
(In millions, except share and per share data)
| | |
(In millions, except share and per share data)
| | Reconciliation to Net Income (Loss) Available to MetLife, Inc.'s
Common Shareholders | | | | | | | | | | | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
1,426
| | |
$
|
1.33
| | |
$
|
1,207
| | |
$
|
1.13
| | | |
$
|
2,889
| | |
$
|
2.70
| | |
$
|
2,525
| | |
$
|
2.36
| | | | | | | | | | | | | | | | | | | | |
|
Adjustments from operating earnings available to common
shareholders to net income (loss) available to MetLife, Inc.'s
common shareholders:
| | | | | | | | | | | | | | | | | | | | |
Add: Net investment gains (losses)
| | | | |
(64
|
)
| | |
(0.06
|
)
| | |
(155
|
)
| | |
(0.14
|
)
| | | |
(174
|
)
| | |
(0.16
|
)
| | |
(254
|
)
| | |
(0.24
|
)
| |
Add: Net derivative gains (losses)
| | | | |
2,092
| | | |
1.96
| | | |
352
| | | |
0.33
| | | | |
114
| | | |
0.11
| | | |
37
| | | |
0.03
| | |
Add: Other adjustments to continuing operations
| | | | |
(725
|
)
| | |
(0.67
|
)
| | |
(446
|
)
| | |
(0.43
|
)
| | | |
(1,135
|
)
| | |
(1.06
|
)
| | |
(660
|
)
| | |
(0.61
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
(460
|
)
| | |
(0.43
|
)
| | |
73
| | | |
0.07
| | | | |
411
| | | |
0.37
| | | |
277
| | | |
0.26
| | |
Add: Income (loss) from discontinued operations, net of income tax
| | | | |
3
| | | |
-
| | | |
31
| | | |
0.03
| | | | |
17
| | | |
0.02
| | | |
(9
|
)
| | |
(0.01
|
)
| |
Less: Net income (loss) attributable to noncontrolling interests
| | | | |
8
| | | |
0.01
| | | |
(7
|
)
| | |
(0.01
|
)
| | | |
32
| | | |
0.03
| | | |
-
| | | |
-
| | |
Less: Preferred stock redemption premium
| | | |
|
-
|
| |
|
-
|
| |
|
-
|
| |
|
-
|
| | |
|
-
|
| |
|
-
|
| |
|
146
|
| |
|
0.14
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
2,264
|
| |
$
|
2.12
|
| |
$
|
1,069
|
| |
$
|
1.00
|
| | |
$
|
2,090
|
| |
$
|
1.95
|
| |
$
|
1,770
|
| |
$
|
1.65
|
| | | | | | | | | | | | | | | | | | | |
| |
Weighted average common shares outstanding - diluted (1)
| | | | | | |
1070.0
| | | | | |
1071.0
| | | | | | |
1069.5
| | | | | |
1069.9
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | |
For the Three Months Ended
| |
For the Six Months Ended
| | | | | | | | | | | | | | June 30,
| | June 30,
| | | | | | | | | | | | | |
|
2012
|
| |
|
2011
|
| |
|
2012
|
| |
|
2011
|
| | | | | | | | | | | | | |
(In millions)
| |
(In millions)
| | | | | | | | | | | Reconciliation to GAAP Premiums, Fees and Other Revenues | | | | | | | | | | | | | | | | | | | | |
Total operating premiums, fees and other revenues
| | | |
$
|
11,602
| | |
$
|
11,636
| | |
$
|
23,207
| | |
$
|
22,468
| | | | | | | | | | | |
Add: Adjustments to premiums, fees and other revenues
| | | |
|
49
|
| |
|
219
|
| |
|
248
|
| |
|
396
|
| | | | | | | | | | |
Total premiums, fees and other revenues
| | | |
$
|
11,651
|
| |
$
|
11,855
|
| |
$
|
23,455
|
| |
$
|
22,864
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | Reconciliation to GAAP Revenues and GAAP Expenses | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Total operating revenues
| | | |
$
|
16,789
| | |
$
|
16,647
| | |
$
|
33,479
| | |
$
|
32,262
| | | | | | | | | | | |
Add: Net investment gains (losses)
| | | | |
(64
|
)
| | |
(155
|
)
| | |
(174
|
)
| | |
(254
|
)
| | | | | | | | | | |
Add: Net derivative gains (losses)
| | | | |
2,092
| | | |
352
| | | |
114
| | | |
37
| | | | | | | | | | | |
Add: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
| | | | |
20
| | | |
1
| | | |
14
| | | |
(2
|
)
| | | | | | | | | | |
Add: Other adjustments to revenues
| | | |
|
(439
|
)
| |
|
301
|
| |
|
881
|
| |
|
1,010
|
| | | | | | | | | | |
Total revenues
| | | |
$
|
18,398
|
| |
$
|
17,146
|
| |
$
|
34,314
|
| |
$
|
33,053
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Total operating expenses
| | | |
$
|
14,754
| | |
$
|
14,888
| | |
$
|
29,355
| | |
$
|
28,591
| | | | | | | | | | | |
Add: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
| | | | |
257
| | | |
112
| | | |
65
| | | |
84
| | | | | | | | | | | |
Add: Other adjustments to expenses
| | | |
|
49
|
| |
|
636
|
| |
|
1,965
|
| |
|
1,584
|
| | | | | | | | | | |
Total expenses
| | | |
$
|
15,060
|
| |
$
|
15,636
|
| |
$
|
31,385
|
| |
$
|
30,259
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | June 30,
| | | | | | | | | | | Reconciliation to Book Value Per Common Share (2) | | | | | | | |
|
2012
|
| |
|
2011
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Book Value Per Common Share Calculation :
| | | | | | | | | | | | | | | | | | | |
Book value per common share, excluding accumulated other
comprehensive income (loss) - (actual common shares outstanding)
| | | | | | | |
$
|
48.60
| | |
$
|
43.24
| | | | | | | | | | | |
Add: Accumulated other comprehensive income (loss) per common share
| | | | | | | |
|
8.23
|
| |
|
3.32
|
| | | | | | | | | | |
Book value per common share - (actual common shares outstanding)
| | | | | | | |
$
|
56.83
|
| |
$
|
46.56
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Common shares outstanding, end of period
| | | | | | | | |
1,062.2
| | | |
1057.4
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| |
| |
| |
| | | MetLife, Inc. | | Reconciliations to Net Income (Loss) Available to Common
Shareholders | | (Unaudited) | | | | | | | | | | |
| | | | |
For the Three Months Ended
| |
For the Six Months Ended
| | | | | June 30,
| | June 30,
| | | | |
|
2012
|
| |
|
2011
|
| |
|
2012
|
| |
|
2011
|
| | | | |
(In millions)
| |
(In millions)
| |
Total The Americas Operations:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
1,128
| | |
$
|
1,015
| | |
$
|
2,286
| | |
$
|
2,039
| | |
Add: Net investment gains (losses)
| | | | |
202
| | | |
16
| | | |
167
| | | |
94
| | |
Add: Net derivative gains (losses)
| | | | |
1,801
| | | |
484
| | | |
694
| | | |
176
| | |
Add: Other adjustments to continuing operations
| | | | |
(435
|
)
| | |
(318
|
)
| | |
(625
|
)
| | |
(405
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
(565
|
)
| | |
(72
|
)
| | |
(99
|
)
| | |
24
| | |
Add: Income (loss) from discontinued operations, net of income tax
| | | | |
3
| | | |
29
| | | |
17
| | | |
50
| | |
Less: Net income (loss) attributable to noncontrolling interest
| | | |
|
1
|
| |
|
-
|
| |
|
1
|
| |
|
-
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
2,133
|
| |
$
|
1,154
|
| |
$
|
2,439
|
| |
$
|
1,978
|
| | | | | | | | | | |
| |
Retail:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
380
| | |
$
|
333
| | |
$
|
788
| | |
$
|
674
| | |
Add: Net investment gains (losses)
| | | | |
52
| | | |
47
| | | |
118
| | | |
82
| | |
Add: Net derivative gains (losses)
| | | | |
960
| | | |
336
| | | |
438
| | | |
262
| | |
Add: Other adjustments to continuing operations
| | | | |
(260
|
)
| | |
(121
|
)
| | |
(364
|
)
| | |
(207
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
(263
|
)
| | |
(91
|
)
| | |
(67
|
)
| | |
(48
|
)
| |
Add: Income (loss) from discontinued operations, net of income tax
| | | |
|
-
|
| |
|
9
|
| |
|
10
|
| |
|
29
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
869
|
| |
$
|
513
|
| |
$
|
923
|
| |
$
|
792
|
| | | | | | | | | | |
| |
Group, Voluntary & Worksite Benefits:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
295
| | |
$
|
228
| | |
$
|
599
| | |
$
|
501
| | |
Add: Net investment gains (losses)
| | | | |
19
| | | |
(8
|
)
| | |
13
| | | |
3
| | |
Add: Net derivative gains (losses)
| | | | |
567
| | | |
177
| | | |
188
| | | |
78
| | |
Add: Other adjustments to continuing operations
| | | | |
(40
|
)
| | |
(37
|
)
| | |
(78
|
)
| | |
(69
|
)
| |
Add: Provision for income tax (expense) benefit
| | | |
|
(192
|
)
| |
|
(47
|
)
| |
|
(43
|
)
| |
|
(5
|
)
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
649
|
| |
$
|
313
|
| |
$
|
679
|
| |
$
|
508
|
| | | | | | | | | | |
| |
Corporate Benefit Funding:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
318
| | |
$
|
325
| | |
$
|
616
| | |
$
|
614
| | |
Add: Net investment gains (losses)
| | | | |
144
| | | |
(10
|
)
| | |
46
| | | |
2
| | |
Add: Net derivative gains (losses)
| | | | |
288
| | | |
(37
|
)
| | |
45
| | | |
(167
|
)
| |
Add: Other adjustments to continuing operations
| | | | |
(7
|
)
| | |
15
| | | |
14
| | | |
55
| | |
Add: Provision for income tax (expense) benefit
| | | | |
(148
|
)
| | |
10
| | | |
(37
|
)
| | |
38
| | |
Add: Income (loss) from discontinued operations, net of income tax
| | | |
|
3
|
| |
|
20
|
| |
|
7
|
| |
|
21
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
598
|
| |
$
|
323
|
| |
$
|
691
|
| |
$
|
563
|
| | | | | | | | | | |
| | Latin America:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
135
| | |
$
|
129
| | |
$
|
283
| | |
$
|
250
| | |
Add: Net investment gains (losses)
| | | | |
(13
|
)
| | |
(13
|
)
| | |
(10
|
)
| | |
7
| | |
Add: Net derivative gains (losses)
| | | | |
(14
|
)
| | |
8
| | | |
23
| | | |
3
| | |
Add: Other adjustments to continuing operations
| | | | |
(128
|
)
| | |
(175
|
)
| | |
(197
|
)
| | |
(184
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
38
| | | |
56
| | | |
48
| | | |
39
| | |
Less: Net income (loss) attributable to noncontrolling interest
| | | |
|
1
|
| |
|
-
|
| |
|
1
|
| |
|
-
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
17
|
| |
$
|
5
|
| |
$
|
146
|
| |
$
|
115
|
| | | | | | | | | | |
| | Asia:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
275
| | |
$
|
171
| | |
$
|
572
| | |
$
|
395
| | |
Add: Net investment gains (losses)
| | | | |
(36
|
)
| | |
(32
|
)
| | |
(139
|
)
| | |
(158
|
)
| |
Add: Net derivative gains (losses)
| | | | |
50
| | | |
5
| | | |
20
| | | |
61
| | |
Add: Other adjustments to continuing operations
| | | | |
5
| | | |
43
| | | |
(1
|
)
| | |
29
| | |
Add: Provision for income tax (expense) benefit
| | | | |
(24
|
)
| | |
10
| | | |
33
| | | |
38
| | |
Add: Income (loss) from discontinued operations, net of income tax
| | | | |
-
| | | |
1
| | | |
-
| | | |
(60
|
)
| |
Less: Net income (loss) attributable to noncontrolling interest
| | | |
|
9
|
| |
|
1
|
| |
|
11
|
| |
|
1
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
261
|
| |
$
|
197
|
| |
$
|
474
|
| |
$
|
304
|
| | | | | | | | | | |
| |
EMEA:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
82
| | |
$
|
64
| | |
$
|
158
| | |
$
|
143
| | |
Add: Net investment gains (losses)
| | | | |
(25
|
)
| | |
(34
|
)
| | |
(18
|
)
| | |
(88
|
)
| |
Add: Net derivative gains (losses)
| | | | |
14
| | | |
(12
|
)
| | |
43
| | | |
7
| | |
Add: Other adjustments to continuing operations
| | | | |
(23
|
)
| | |
(34
|
)
| | |
(5
|
)
| | |
(47
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
39
| | | |
6
| | | |
13
| | | |
26
| | |
Less: Net income (loss) attributable to noncontrolling interest
| | | |
|
(5
|
)
| |
|
(3
|
)
| |
|
17
|
| |
|
4
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
92
|
| |
$
|
(7
|
)
| |
$
|
174
|
| |
$
|
37
|
| | | | | | | | | | |
| |
Corporate & Other:
| | | | | | | | | | | |
Operating earnings available to common shareholders
| | | |
$
|
(59
|
)
| |
$
|
(43
|
)
| |
$
|
(127
|
)
| |
$
|
(52
|
)
| |
Add: Net investment gains (losses)
| | | | |
(205
|
)
| | |
(105
|
)
| | |
(184
|
)
| | |
(102
|
)
| |
Add: Net derivative gains (losses)
| | | | |
227
| | | |
(125
|
)
| | |
(643
|
)
| | |
(207
|
)
| |
Add: Other adjustments to continuing operations
| | | | |
(272
|
)
| | |
(137
|
)
| | |
(504
|
)
| | |
(237
|
)
| |
Add: Provision for income tax (expense) benefit
| | | | |
90
| | | |
129
| | | |
464
| | | |
189
| | |
Add: Income (loss) from discontinued operations, net of income tax
| | | | |
-
| | | |
1
| | | |
-
| | | |
1
| | |
Less: Net income (loss) attributable to noncontrolling interest
| | | | |
3
| | | |
(5
|
)
| | |
3
| | | |
(5
|
)
| |
Less: Preferred stock redemption premium
| | | |
|
-
|
| |
|
-
|
| |
|
-
|
| |
|
146
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
(222
|
)
| |
$
|
(275
|
)
| |
$
|
(997
|
)
| |
$
|
(549
|
)
|
|
|
|
| |
| |
| |
| | | MetLife, Inc. | | GAAP Interim Condensed Consolidated Statements of Operations | | (Unaudited) | | | | | | | | | | |
| | | | |
For the Three Months Ended
| |
For the Six Months Ended
| | | | | June 30,
| | June 30,
| | | | |
|
2012
|
| |
|
2011
|
| |
|
2012
|
| |
|
2011
|
| | | | |
(In millions)
| | Revenues | | | | | | | | | | | |
Premiums
| | | |
$
|
9,161
| | |
$
|
9,294
| | |
$
|
18,290
| | |
$
|
17,848
| | |
Universal life and investment-type product policy fees
| | | | |
2,097
| | | |
1,969
| | | |
4,175
| | | |
3,858
| | |
Net investment income
| | | | |
4,719
| | | |
5,094
| | | |
10,919
| | | |
10,406
| | |
Other revenues
| | | | |
393
| | | |
592
| | | |
990
| | | |
1,158
| | |
Net investment gains (losses):
| | | | | | | | | | | |
Other-than-temporary impairments on fixed maturity securities
| | | | |
(118
|
)
| | |
(298
|
)
| | |
(253
|
)
| | |
(430
|
)
| |
Other-than-temporary impairments on fixed maturity securities
| | | | | | | | | | | |
transferred to other comprehensive income (loss)
| | | | |
27
| | | |
175
| | | |
29
| | | |
184
| | |
Other net investment gains (losses)
| | | |
|
27
|
| |
|
(32
|
)
| |
|
50
|
| |
|
(8
|
)
| |
Total net investment gains (losses)
| | | | |
(64
|
)
| | |
(155
|
)
| | |
(174
|
)
| | |
(254
|
)
| |
Net derivative gains (losses)
| | | |
|
2,092
|
| |
|
352
|
| |
|
114
|
| |
|
37
|
| |
Total revenues
| | | |
|
18,398
|
| |
|
17,146
|
| |
|
34,314
|
| |
|
33,053
|
| | | | | | | | | | |
| | Expenses | | | | | | | | | | | |
Policyholder benefits and claims
| | | | |
8,911
| | | |
9,121
| | | |
18,015
| | | |
17,358
| | |
Interest credited to policyholder account balances
| | | | |
1,022
| | | |
1,442
| | | |
3,579
| | | |
3,366
| | |
Policyholder dividends
| | | | |
352
| | | |
374
| | | |
695
| | | |
746
| | |
Other expenses
| | | |
|
4,775
|
| |
|
4,699
|
| |
|
9,096
|
| |
|
8,789
|
| |
Total expenses
| | | |
|
15,060
|
| |
|
15,636
|
| |
|
31,385
|
| |
|
30,259
|
| | | | | | | | | | |
| |
Income (loss) from continuing operations before provision for income
tax
| | | | |
3,338
| | | |
1,510
| | | |
2,929
| | | |
2,794
| | |
Provision for income tax expense (benefit)
| | | |
|
1,038
|
| |
|
448
|
| |
|
763
|
| |
|
808
|
| |
Income (loss) from continuing operations, net of income tax
| | | | |
2,300
| | | |
1,062
| | | |
2,166
| | | |
1,986
| | |
Income (loss) from discontinued operations, net of income tax
| | | |
|
3
|
| |
|
31
|
| |
|
17
|
| |
|
(9
|
)
| |
Net income (loss)
| | | | |
2,303
| | | |
1,093
| | | |
2,183
| | | |
1,977
| | |
Less: Net income (loss) attributable to noncontrolling interests
| | | |
|
8
|
| |
|
(7
|
)
| |
|
32
|
| |
|
-
|
| |
Net income (loss) attributable to MetLife, Inc. | | | | |
2,295
| | | |
1,100
| | | |
2,151
| | | |
1,977
| | |
Less: Preferred stock dividends
| | | | |
31
| | | |
31
| | | |
61
| | | |
61
| | |
Preferred stock redemption premium
| | | |
|
-
|
| |
|
-
|
| |
|
-
|
| |
|
146
|
| |
Net income (loss) available to MetLife, Inc.'s common shareholders
| | | |
$
|
2,264
|
| |
$
|
1,069
|
| |
$
|
2,090
|
| |
$
|
1,770
|
|
| | |
|
(1)
|
|
For the three and six months ended June 30, 2012, all shares
related to the assumed issuance of shares in settlement of the
applicable purchase contracts of the common equity units have been
excluded from the weighted average common shares outstanding -
diluted, as these assumed shares would be anti-dilutive to
operating earnings available to common shareholders per common
share - diluted and net income available to MetLife, Inc.’s common
shareholders per common share - diluted.
| | |
| |
(2)
| |
Book value per common share and book value per common share,
excluding accumulated other comprehensive income (loss) exclude
$2,043 million of equity related to preferred stock.
|

MetLife, Inc. For Media: Christopher Breslin, 212-578-8824 or For
Investors: John McCallion, 212-578-7888
Source: MetLife, Inc. | Copyright: | Copyright Business Wire 2012 | | Wordcount: | 6149 |
SHARE THIS:
USER COMMENTS:
Denotes premium content. Learn more about becoming an Insider here.
|